#cipla shares

[aksarnews]

Pharma Stocks Gain After Centre Approves Use Of COVID Pill Molnupiravir

Pharma Stocks Gain After Centre Approves Use Of COVID Pill Molnupiravir

The government also approved two ne vaccines Corbevax and Covovax yesterday Pharmaceutical shares such as Cipla, Dr Reddy’s Laboratories, Torrent Pharmaceuticals, Sun Pharmaceutical Industries gained around two per cent each on Wednesday, December 29, after the Drug Controller General of India (DCGI) approved the emergency use of anti-viral drug – Molnupiravir in the country. to fight against…

View On WordPress

[hummingzone]

Top Stocks to Buy – Amid high market volatility, analyst Sandeep Jain recommends Cipla, Timken India, KEC International for bumper returns

Top Stocks to Buy – Amid high market volatility, analyst Sandeep Jain recommends Cipla, Timken India, KEC International for bumper returns

The stock markets on Friday traded with high volatility. The markets opened without much noise and then fell steeply. Nifty 50 had a free fall and touching around levels of 15,450 on the intraday basis which was a crucial level. The previous lifetime was 15,431 and the markets took a support at this level. Market Analyst Sandeep Jain said that last trading session of the week was extremely action…

View On WordPress

[khabrisala]

Market LIVE: Indian stocks seen under pressure; SGX Nifty down 0.5%

Market LIVE: Indian stocks seen under pressure; SGX Nifty down 0.5%

[ad_1]

Welcome to the Mint live blog. Track this space for latest stock market updates.

14 Jul 2020, 08:36:32 AM IST Asian Shares Asian stocks slipped Tuesday, following their US peers lower amid fresh Sino-American tensions and concern over the economic impact of rising coronavirus…

View On WordPress

[goldsilverreports]

Cipla Shares Decline As Regulatory Concerns Prevail At Pithampur Unit

Cipla Shares Decline As Regulatory Concerns Prevail At Pithampur Unit

Gold Silver Reports (GSR) – Cipla Shares Decline As Regulatory Concerns Prevail At Pithampur Unit – Shares of the drug maker fell as much as 2.9 percent to Rs 572.15. The pharmaceutical company received three observations from the U.S. drug regulator for its Pithampur unit, according to its exchange filing.

(more…)

View On WordPress

[goldsilverreports]

Cipla Shares Rise 4.2% On Heavy Trading Volume

Cipla Shares Rise 4.2% On Heavy Trading Volume

Cipla Shares Rise 4.2% On Heavy Trading Volume – Shares of the drugmaker rose 4.2 percent to Rs 579, the highest level since March 12. Trading volume was more than triple the 20-day average for this time of day. The stock is at an 11 percent discount to the analysts’ consensus target price. It traded at an average 2.7 percent discount over the past year.

View On WordPress